Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Celularity (CELU) Other Non-Current Assets (2020 - 2025)

Celularity (CELU) has disclosed Other Non-Current Assets for 6 consecutive years, with $220000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Other Non-Current Assets fell 97.84% to $220000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $220000.0, a 97.84% decrease, with the full-year FY2024 number at $10.2 million, up 2938.28% from a year prior.
  • Other Non-Current Assets was $220000.0 for Q3 2025 at Celularity, down from $242000.0 in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $14.8 million in Q1 2022 to a low of $220000.0 in Q3 2025.
  • A 5-year average of $5.5 million and a median of $365500.0 in 2021 define the central range for Other Non-Current Assets.
  • Biggest YoY gain for Other Non-Current Assets was 2938.28% in 2024; the steepest drop was 97.94% in 2024.
  • Celularity's Other Non-Current Assets stood at $355000.0 in 2021, then increased by 5.92% to $376000.0 in 2022, then decreased by 10.37% to $337000.0 in 2023, then soared by 2938.28% to $10.2 million in 2024, then plummeted by 97.85% to $220000.0 in 2025.
  • Per Business Quant, the three most recent readings for CELU's Other Non-Current Assets are $220000.0 (Q3 2025), $242000.0 (Q2 2025), and $10.0 million (Q1 2025).